危急疾病中的PCSK9 - 这不仅仅是脂质
Emma Crossley1, Jonathan A Silversides1,2, Cecilia M O'Kane1,2
1Wellcome-Wolfson Institute for Experimental Medicine, Queen's University Belfast, Belfast, UK.
Annals of clinical biochemistry
|October 27, 2025
概括
蛋白转化酶亚素-素9型 (PCSK9) 通过影响LDL受体来调节胆固醇. 新兴研究还表明PCSK9在炎症和严重疾病中起作用.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 免疫学 免疫学 免疫学
背景情况:
- 蛋白转化酶亚素-素9型 (PCSK9) 对于脂质代谢至关重要.
- PCSK9与低密度脂蛋白受体 (LDLR) 结合,抑制LDL胆固醇 (LDLc) 清除.
- PCSK9是高胆固醇血症的治疗点,单克隆抗体的发展迅速.
研究的目的:
- 探索PCSK9在脂质代谢和炎症中的双重作用.
- 研究PCSK9作为超越高胆固醇血症的治疗点的潜力.
主要方法:
- 对PCSK9功能现有文献的审查.
- 对研究PCSK9在严重疾病中的研究进行分析.
主要成果:
- PCSK9在通过LDLR减少LDLc清除中的确立作用.
- 在诸如败血症和ARDS等危急条件下观察到PCSK9水平升高.
- 假设PCSK9在损害细菌内毒素清除和加剧炎症中的作用.
结论:
- PCSK9是脂质代谢和炎症过程的关键调节者.
- 需要进一步的研究来阐明PCSK9在肝外组织中的功能.
- 药理上抑制PCSK9可能会带来更广泛的治疗效益.
相关概念视频
Atherosclerosis III: Management
312
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
312
Coronary Artery Disease V: Interprofessional Care
210
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
210
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
Coronary Artery Disease I: Introduction
869
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
869
Peripheral Artery Disease III: Interprofessional Care
236
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
236
Acute Coronary Syndrome IV: Interprofessional Care
214
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
214


